SU1523045A3 - Method of producing preparation for curing wounds - Google Patents
Method of producing preparation for curing wounds Download PDFInfo
- Publication number
- SU1523045A3 SU1523045A3 SU853886807A SU3886807A SU1523045A3 SU 1523045 A3 SU1523045 A3 SU 1523045A3 SU 853886807 A SU853886807 A SU 853886807A SU 3886807 A SU3886807 A SU 3886807A SU 1523045 A3 SU1523045 A3 SU 1523045A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- calcium
- potassium
- ions
- mmol
- formulations
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 6
- 206010052428 Wound Diseases 0.000 title claims description 10
- 208000027418 Wounds and injury Diseases 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 239000013543 active substance Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 9
- 229910052700 potassium Inorganic materials 0.000 claims description 9
- 229910001424 calcium ion Inorganic materials 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- 229910001414 potassium ion Inorganic materials 0.000 claims description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 238000002474 experimental method Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 230000029663 wound healing Effects 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 229920013820 alkyl cellulose Polymers 0.000 claims 1
- 159000000007 calcium salts Chemical class 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 claims 1
- 159000000011 group IA salts Chemical class 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000008092 positive effect Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 abstract description 16
- 150000003839 salts Chemical class 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract 4
- 150000002500 ions Chemical class 0.000 abstract 2
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 239000008213 purified water Substances 0.000 description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 5
- 229960003415 propylparaben Drugs 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical class N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical class [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229940046413 calcium iodide Drugs 0.000 description 1
- 229910001640 calcium iodide Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical class [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Chemical group 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- -1 calcium sugars Chemical class 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Изобретение относитс к химико- фармацевтической нромышленности и касаетс способа приготовлени средства дл заживлени ран.The invention relates to the chemical and pharmaceutical industry and concerns a method for preparing a wound healing agent.
Целью изобретени вл етс улучшение заживлени ран за счет гомогенного распределени активного вещества.The aim of the invention is to improve wound healing due to the homogeneous distribution of the active substance.
Изобретение иллюстрируетс следую-- щими пр им ер ами.The invention is illustrated by the following rules.
Пример 1.94г очищенной воды нагревают до 70 С и смешивают с 0,3 г хлористого кали (40 ммоль калиевых ионов) и 0,44 г хлористого кальци (30 ммоль кальциевых ионов)„ После прибавлени 0,2 г пропилпарабена в получаемом растворе диспергируют 5 г метилоксизтилцеллюлозы. После перемешивани охлаждают до комнатной температуры . После остывани получают высоков зкий , содержащий воздушные пузырьки гель с в зкостью, равной 90 , который можно использовать непосредственно дл лечени ран„ Анализ показывает , что активное вещество равномерно распределено в геле.Example 1.94 g of purified water is heated to 70 ° C and mixed with 0.3 g of potassium chloride (40 mmol of potassium ions) and 0.44 g of calcium chloride (30 mmol of calcium ions). After adding 0.2 g of propyl paraben in the resulting solution, it is dispersed 5 g of methyloxystilcellulose. After stirring, cool to room temperature. After cooling, a highly viscous gel containing air bubbles with a viscosity of 90 is obtained, which can be used directly to treat wounds. The analysis shows that the active substance is evenly distributed in the gel.
Пример 2. Осуществл ют аналогично примеру 1, но вместо пропилпарабена используют 0,2 г метилпара- бена. После остывани получают высоков зкий , содержа1 у1й воздушные пузырьки гель с в зкостью, равной 90 Па-с, который можно использовать непосредственно дл лечени ран. Анализ, показывает , что активное вещество равномерно распределено в геле.Example 2. The procedure was carried out as in Example 1, but instead of propyl paraben, 0.2 g of methyl paraben was used. After cooling, a highly viscous gel containing 90 air-bubbles with a viscosity of 150 Pa-s is obtained, which can be used directly for the treatment of wounds. The analysis shows that the active substance is evenly distributed in the gel.
Пример 3. 40 г очищенной воды нагревают до 80°С и смешивают с 0,3 г хлористого кали (40 ммоль калиевых -ионов) и 0,44 г хлористого кальци (30 ммоль кальциевых ионов).Example 3. 40 g of purified water are heated to 80 ° C and mixed with 0.3 g of potassium chloride (40 mmol of potassium ions) and 0.44 g of calcium chloride (30 mmol of calcium ions).
СЛSL
toto
:о:about
4: СЛ4: SL
смcm
После прибавлени 0,18 г метилпарабе- наJ1 0,02 г пропилпарабена в получ&е- мом растворе диспергируют 4,5 г ме- тилоксиэтилцеллюлозы. Затем добавл - ют 54,56 г холодной очищенной воды и, перемешива , охлаждают до комнатной температуры. После остывани получают содержащий воздушные пузырьки гель с в зкостью, равной 50 Па.с, который можно использовать непосредственно дл лечени ран Анализ показывает,. что активное вещество равномерно распределено в геле.After adding 0.18 g of methylparaben-J1, 0.02 g of propyl paraben in the resulting solution is dispersed 4.5 g of methyloxyethylcellulose. Then 54.56 g of cold purified water are added and, with stirring, cooled to room temperature. After cooling, an air-containing gel with a viscosity of 50 Pa.s is obtained, which can be used directly to treat wounds. Analysis shows. that the active substance is evenly distributed in the gel.
Пример 4. 55,06 г очищенной воды нагревают до 60 С и смешивают с 0,3 г хлористого кали (40 ммоль калиевых ионов) и г хлористого кальци (40 ммоль кальциевых ионов), После прибавлени 0,2 г этилпарабена в получаемом растворе диспергируют 4 г метилоксиэтилцеллюлозы. Затем.добавл ют 40 г холодной очищенной воды и,перемешива 5 охлаждают до комнатной температуры. После остывани получа- ют содержащий воздушные пузырьки гель с в зкостью, равной 40 Па-с, который можно использовать непосредственно дл лечени ран. Анализ,показывает, что активное вещество равномерно рас- пределено в геле,Example 4. 55.06 g of purified water is heated to 60 ° C and mixed with 0.3 g of potassium chloride (40 mmol of potassium ions) and g of calcium chloride (40 mmol of calcium ions). After adding 0.2 g of ethyl paraben in the resulting solution is dispersed 4 g of methyloxyethylcellulose. Then, 40 g of cold purified water is added and, by stirring, 5 is cooled to room temperature. After cooling, a gel containing air bubbles with a viscosity of 40 Pa-s is obtained, which can be used directly to treat wounds. Analysis shows that the active substance is evenly distributed in the gel,
Пример 5. 88 г очищенной воды нагревают до бО.С и смешивают с 0,3 г хлористого кали (40 ммоль калиевых ионов) и 0,44 г хлористого кальци (30 ммоль кальциевых ионов), После прибавлени О , 2 г пропилпарабена , 1,8 г метилпарабейа и 2,8 г сорбита в виде 70%-ного водного раствора в получаемом растворе дисперги- руют 4 г метилоксиэтилцеллюлозы. Затем , перемешива , охлаждают до комнатной температуры. После остывани получают содержащий.воздушные пузырьки гель с в зкостью, равной 35 Па-с, который можно использовать непосредственно дл лечени ран. Анализ пока зывает, что активное вещество равномерно распределено в геле.Example 5. 88 g of purified water are heated to BOC and mixed with 0.3 g of potassium chloride (40 mmol of potassium ions) and 0.44 g of calcium chloride (30 mmol of calcium ions). After adding 0, 2 g of propyl paraben, 1 , 8 g methylparabate and 2.8 g sorbitol in the form of a 70% aqueous solution in the resulting solution are dispersed 4 g of methyloxyethylcellulose. Then, stirring, cooled to room temperature. After cooling, a gel containing air bubbles with a viscosity of 35 Pa-s is obtained, which can be used directly to treat wounds. The analysis shows that the active substance is evenly distributed in the gel.
Пример 6. Осуществл ют ана- .логично примеру 5, но используют 70% ньш водньй раствор, содержащий а) 2 г этилпарабена и 2,8 г сорбита, б). 2 г . метилпарабена и г сорбита или в) 2 г пропилпарабена и 2,8 г сорбитаExample 6. The procedure is carried out in analogy to Example 5, but using 70% N's aqueous solution containing a) 2 g of ethyl paraben and 2.8 g of sorbitol, b). 2 g. methyl paraben and g sorbitol or c) 2 g propyl paraben and 2.8 g sorbitol
После отсасьгоани во всех случа х а) в) содержащий воздушны пузырьки гель с в зкостью, равнойAfter removal, in all cases a) c) a gel containing air bubbles with a viscosity equal to
5 0 5 5 0 5
Q Q
5five
50 , который можно использовать непосредственно дл лечени ран. Анализ показывает, что активное вещество равномерно распределено в геле а) - в).50, which can be used directly to treat wounds. The analysis shows that the active substance is evenly distributed in the gel a) - c).
Пример 7, Осуществл ют аналогично примеру 5, однако 40 ммоль калиевых и 30 ммоль кальциевых ионов используют в виде смесиExample 7 Carried out as in Example 5, however, 40 mmol of potassium and 30 mmol of calcium ions are used as a mixture.
а)ацетатов кали и кальци ,a) potassium and calcium acetates,
б)глюконатов кали и кальци ,b) potassium and calcium gluconates,
в)йодида кали и йодида кальци в виде гексагидрата,c) potassium iodide and calcium iodide as hexahydrate,
г)лактатов кали и кальци ,d) potassium and calcium lactates,
д)пантогенатов кали и кальци ,e) potassium and calcium pantogenates,
е)первичных фосфатов кали и капьe) primary potassium phosphate and drip
ЦИЯ,CII,
ж)третичных фосфатов кали и кальци ,g) tertiary potassium and calcium phosphates,
з)сахаратов кали и кальци , . и) салицилатов кали и кальци ,h) potassium and calcium sugars,. i) salicylates of potassium and calcium,
к) в виде соответствующих солей пенициллина .a) in the form of the corresponding salts of penicillin.
Во всех случа х получают средство с равномерно распределенным в нем активным веществом.In all cases, an agent with the active substance uniformly distributed in it is obtained.
Пример 8, Кожу спины морской свинки раздел ют до фасции и в эту рану вшивают кольцо из тефлона диаметром 21 мм с тем, чтобы предотвратить эпителиальное закрытие раны. На фасцию мускулатуры спины, котора в момент операции свободна от гранул ционной ткани, нанос т средства по примерам 1-5, 6а-6в, 7а-7к, а также средство по прототипу (гель на основе полиакриламида и желатины в соотношении 1:1, на который нанесено 0,9% хлористого натри в качестве активно- го вещества, торговьй продукт Гели- перм).Example 8 The skin of the back of a guinea pig is divided to the fascia and a ring of Teflon with a diameter of 21 mm is sewn into this wound in order to prevent epithelial wound closure. The fascia of the back muscles, which at the time of the operation is free of granulation tissue, are applied with the preparations of examples 1-5, 6a-6b, 7a-7k, as well as the prototype (gel based on polyacrylamide and gelatin in a 1: 1 ratio, on which 0.9% sodium chloride is applied as the active substance, the trade product is Gel).
Количество,образовавшейс при использовании средства примеров 1-7 гранул ционной ткани определ ют в процентах от количества ткани, образовавшейс при использовании известного средства „ При этом были получены следующие результаты: средства примеров 1-5 - 180, 190 и 195% соответственно, а, средства.примеров 6а-6в, 7а-7к - 195, 192, 195., 193, 195, 190, 198, 188,, 190, 192, 195,195 и 205% соответственно .,The amount formed by using the means of examples 1-7 of granulation tissue is determined as a percentage of the amount of fabric formed by using the known means. The following results were obtained: the means of examples 1-5-180, 190 and 195%, respectively, a, examples 6a-6b, 7a-7k - 195, 192, 195., 193, 195, 190, 198, 188 ,, 190, 192, 195.195 and 205% respectively.,
Пример 9, Повтор ют пример 8.с той разницей, что используют средство примера 1, при приготовлении которого кальциевые и калиевые ионы используют в количестве 27 и 36 ммольExample 9, Example 8 is repeated. With the difference that the means of Example 1 is used, in the preparation of which calcium and potassium ions are used in the amount of 27 and 36 mmol
соответственно (опыт А) или 33 и А4 ммоль соответственно (опыт Б), При этом бьши получены следующие результаты; опыт А - 105%, опыт Б - 160%.respectively (experiment A) or 33 and A4 mmol respectively (experiment B), and the following results were obtained; Experience A - 105%; Experience B - 160%.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3416777A DE3416777C2 (en) | 1984-05-07 | 1984-05-07 | Topical pharmaceutical preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1523045A3 true SU1523045A3 (en) | 1989-11-15 |
Family
ID=6235108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU853886807A SU1523045A3 (en) | 1984-05-07 | 1985-05-06 | Method of producing preparation for curing wounds |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS60239421A (en) |
DE (1) | DE3416777C2 (en) |
SU (1) | SU1523045A3 (en) |
ZA (1) | ZA853432B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997000667A1 (en) * | 1995-06-22 | 1997-01-09 | Minnesota Mining And Manufacturing Company | Stable hydroalcoholic compositions |
US7566460B2 (en) | 1995-06-22 | 2009-07-28 | 3M Innovative Properties Company | Stable hydroalcoholic compositions |
US6623744B2 (en) * | 1995-06-22 | 2003-09-23 | 3M Innovative Properties Company | Stable hydroalcoholic compositions |
CA2224702C (en) | 1995-06-22 | 2013-01-08 | Robert A. Asmus | Stable hydroalcoholic compositions |
DE19622708A1 (en) * | 1996-06-05 | 1997-12-11 | Tomic Dobrivoje | Aqueous compositions containing betaine |
US6582711B1 (en) | 1997-01-09 | 2003-06-24 | 3M Innovative Properties Company | Hydroalcoholic compositions thickened using polymers |
US6019997A (en) * | 1997-01-09 | 2000-02-01 | Minnesota Mining And Manufacturing | Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents |
US5908619A (en) * | 1997-01-09 | 1999-06-01 | Minnesota Mining And Manufacturing Company | Hydroalcoholic compositions thickened using surfactant/polymer complexes |
AU2002359529B2 (en) * | 2001-11-29 | 2008-02-21 | Greystone Medical Group, Inc. | Treatment of wounds and compositions employed |
CA2511440A1 (en) * | 2002-12-23 | 2004-07-15 | Greystone Medical Group, Inc. | Reduction of reactive oxygen species in chronic wound management |
JP6133858B2 (en) * | 2011-07-28 | 2017-05-24 | スリーエム イノベイティブ プロパティズ カンパニー | Wound healing composition and method of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2725261C2 (en) * | 1977-06-03 | 1986-10-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Transparent liquid dressing material, its manufacture and use |
GB8324487D0 (en) * | 1983-09-13 | 1983-10-12 | Geistlich Soehne Ag | Topically administrable pharmaceutical compositions |
-
1984
- 1984-05-07 DE DE3416777A patent/DE3416777C2/en not_active Expired
-
1985
- 1985-05-02 JP JP60094007A patent/JPS60239421A/en active Pending
- 1985-05-06 SU SU853886807A patent/SU1523045A3/en active
- 1985-05-07 ZA ZA853432A patent/ZA853432B/en unknown
Non-Patent Citations (1)
Title |
---|
За вка DE № 2725261, кл. А 61 L 15/03. опублик. 1978. * |
Also Published As
Publication number | Publication date |
---|---|
DE3416777A1 (en) | 1985-11-07 |
DE3416777C2 (en) | 1986-11-20 |
ZA853432B (en) | 1985-12-24 |
JPS60239421A (en) | 1985-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1523045A3 (en) | Method of producing preparation for curing wounds | |
US4546195A (en) | Process for the production of amino-dicarboxylic acid-bivalent metal-halogen complexes and such complexes | |
US3252859A (en) | Colloidal silica-oil composition and method of using same | |
ES8101068A1 (en) | Amino-pyrimidine-carbanilides, process for their preparation, medicines containing them. | |
PT71727A (en) | Process for preparing a pharmaceutical composition particularly suitable for cancer treatment | |
US2607658A (en) | Aluminum chlorhydroxy and borate gels | |
US3361769A (en) | Bi-metallic salts of gluconic, glucuronic, or galacturonic acid | |
US4709712A (en) | Polycarboxylic acid polymer gels as protective agents | |
US2907781A (en) | Monohydroxy magnesium aluminum salt of an amino aliphatic acid and method of preparing same | |
JPH0364483B2 (en) | ||
US3553148A (en) | Method of making a calcium gel and the product of this method | |
JP2864251B2 (en) | Antibacterial titanium oxide and method for producing the same | |
JP2538213B2 (en) | Super absorbent composition | |
US4139612A (en) | Process for making an aluminum phosphate gel | |
US3686164A (en) | Sulfuric acid monoesters of tragacanth and process for the preparation thereof | |
CA1070299A (en) | Stabilized solid form choline salicylate compositions | |
US2686800A (en) | Basic aluminum para-amino salicylate and method of making | |
KR870002160B1 (en) | Method of making modified clay | |
JPS5835108A (en) | Bath salts for medical purpose | |
CA1243953A (en) | High-density antacid powders | |
RU1838318C (en) | Method for producing tysole complex of tetracoptane hydrotetrakis(oxy -3,4-dihydroxypropyl)titanium with decane -1,23-trihydroxypropane having transcutaneous conductivity of medicamentous additives | |
JPS5835107A (en) | Bath salts for medical purpose | |
SU833241A1 (en) | Method of obtaining ointment | |
RU2097023C1 (en) | Method of preparing an ointment for suppurative local wound treatment | |
JPS62114916A (en) | External preparation for skin |